Ruth Camargo Vassão

AddressBrazil
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in Spetember 2020 and June 2021 and August 2021
    All Publications
    Bar chart showing 13 publications over 9 distinct years, with a maximum of 2 publications in 2003 and 2009 and 2016 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ferrante L, Duczmal L, Steinmetz WA, Almeida ACL, Leão J, Vassão RC, Tupinambás U, Fearnside PM. How Brazil's President turned the country into a global epicenter of COVID-19. J Public Health Policy. 2021 Sep; 42(3):439-451. PMID: 34453095.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Ferrante L, Livas S, Steinmetz WA, Almeida ACL, Leão J, Vassão RC, Tupinambás U, Fearnside PM, Duczmal LH. The First Case of Immunity Loss and SARS-CoV-2 Reinfection by the Same Virus Lineage in Amazonia. J Racial Ethn Health Disparities. 2021 08; 8(4):821-823. PMID: 34155594.
      Citations: 1     Fields:    Translation:Humans
    3. Ferrante L, Steinmetz WA, Almeida ACL, Leão J, Vassão RC, Tupinambás U, Fearnside PM, Duczmal LH. Brazil's policies condemn Amazonia to a second wave of COVID-19. Nat Med. 2020 09; 26(9):1315. PMID: 32770168.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    4. Vassão RC, Consales CA, Sant'Anna OA, Pereira CA. Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3. Immunobiology. 2003; 207(4):275-83. PMID: 12952350.
      Citations:    Fields:    Translation:AnimalsCells
    5. Vassão RC, de Franco MT, Hartz D, Modolell M, Sippel AE, Pereira CA. Down-regulation of Bgp1(a) viral receptor by interferon-gamma is related to the antiviral state and resistance to mouse hepatitis virus 3 infection. Virology. 2000 Sep 01; 274(2):278-83. PMID: 10964771.
      Citations: 5     Fields:    Translation:AnimalsCells
    6. Vassão RC, Cabrera WH, Ibanez OC, Pereira CA. Specific T-cell response correlates with resistance of genetic heterogeneous mouse populations to mouse hepatitis virus 3 infection. Arch Virol. 1995; 140(7):1235-45. PMID: 7646354.
      Citations:    Fields:    Translation:AnimalsCells
    7. Vassão R, Pereira CA. Antiviral activity of interferon gamma in vivo during mouse hepatitis virus infection. Braz J Med Biol Res. 1994 Oct; 27(10):2407-11. PMID: 7640631.
      Citations:    Fields:    Translation:AnimalsCellsPHPublic Health
    8. Vassão RC, Sant' Anna OA, Pereira CA. A genetic analysis of macrophage activation and specific antibodies in relation to the resistance of heterogeneous mouse populations to MHV3 infection. Arch Virol. 1994; 139(3-4):417-25. PMID: 7832646.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    9. Vassão RC, Mello IG, Pereira CA. Role of macrophages, interferon gamma and procoagulant activity in the resistance of genetic heterogeneous mouse populations to mouse hepatitis virus infection. Arch Virol. 1994; 137(3-4):277-88. PMID: 7944950.
      Citations: 2     Fields:    Translation:AnimalsCells
    10. Lucchiari MA, Modolell M, Vassão RC, Pereira CA. TNF alpha, IL-1 and O2- release by macrophages do not correlate with the anti-mouse hepatitis virus 3 effect induced by interferon gamma. Microb Pathog. 1993 Dec; 15(6):447-54. PMID: 8007817.
      Citations: 1     Fields:    Translation:AnimalsCells
    11. Vassão R, Russo M, Marcondes MC, Pereira CA. Resistance of genetically selected mice to MHV3 infection is not dependent on the H2O2 release by macrophages. Microb Pathog. 1993 Mar; 14(3):169-76. PMID: 8391622.
      Citations: 2     Fields:    Translation:AnimalsCells
    12. Mello IG, Vassão RC, Pereira CA. Virus specificity of the antiviral state induced by IFN gamma correlates with resistance to MHV 3 infection. Arch Virol. 1993; 132(3-4):281-9. PMID: 7691047.
      Citations: 7     Fields:    Translation:AnimalsCells
    13. Damy SB, Vassão RC, Lucchiari MA, Pereira CA, Sant'Anna OA. A comparative study of resistance to MHV3 infection in genetically homogeneous and heterogeneous mouse populations. Braz J Med Biol Res. 1992; 25(10):1025-7. PMID: 1342823.
      Citations: 3     Fields:    Translation:AnimalsCells